Comparison of the expression of COMP in the stroma of the primary tumors with the expression of cancer cells in the lymph node metastasis showed that 2 pairs had gained expression, 4 pairs had retained expression, and 26 pairs had lost the expression of COMP in lymph node metastases (p < 0.001; Table S3). Here, COMP is linked to cancer.